Efficacy and safety of once-weekly semaglutide versus once-daily insulin glargine as add-on to metformin (with or without sulfonylureas) in insulin-naive patients with type 2 diabetes (SUSTAIN 4): a randomised, open-label, parallel-group, multicentr (Q53399727)
Jump to navigation
Jump to search
scientific article published on 23 March 2017
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy and safety of once-weekly semaglutide versus once-daily insulin glargine as add-on to metformin (with or without sulfonylureas) in insulin-naive patients with type 2 diabetes (SUSTAIN 4): a randomised, open-label, parallel-group, multicentr |
scientific article published on 23 March 2017 |
Statements
Efficacy and safety of once-weekly semaglutide versus once-daily insulin glargine as add-on to metformin (with or without sulfonylureas) in insulin-naive patients with type 2 diabetes (SUSTAIN 4): a randomised, open-label, parallel-group, multicentr (English)
1 reference
Vanita R Aroda
Stephen C Bain
Bertrand Cariou
Milivoj Piletič
Ludger Rose
Mads Axelsen
Everton Rowe
J Hans DeVries
23 March 2017
5
5
355-366